Delirium and agitation at the end of life

BMJ (Online)

Volumn 353, Issue , 2016, Pages

  Hosker, Christian M G ^a   Bennett, Michael I ^b  

^a LEEDS AND YORK PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; LEVOMEPROMAZINE; LORAZEPAM; OLANZAPINE;

AGITATION; ARTICLE; BEHAVIOR CHANGE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DELIRIUM; DISEASE PREDISPOSITION; DISEASE SEVERITY; END OF LIFE; ENVIRONMENT; ENVIRONMENTAL FACTOR; EVIDENCE BASED MEDICINE; FAMILY COUNSELING; HUMAN; HYDRATION; LIFE EVENT; MEDICAL DECISION MAKING; PALLIATIVE THERAPY; PARENTERAL NUTRITION; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SAFE OPTIMIZED ENVIRONMENT; SCREENING; SEDATION; SYMPTOM; SYMPTOM CONTROL; DISEASE MANAGEMENT; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; PSYCHOMOTOR AGITATION; TERMINAL CARE; TERMINALLY ILL PATIENT;

DELIRIUM; DISEASE MANAGEMENT; HUMANS; PSYCHOMOTOR AGITATION; TERMINAL CARE; TERMINALLY ILL;

EID: 84974705009     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i3085     Document Type: Article

References (38)

1. Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 2000;160:786-94. doi:10.1001/archinte.160.6.786 pmid:10737278.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. (5th ed): DSM-5. 2013
3. Hosie A, Agar M, Lobb E, Davidson PM, Phillips J. Palliative care nurses' recognition and assessment of patients with delirium symptoms: a qualitative study using critical incident technique. Int J Nurs Stud 2014;51:1353-65. doi:10.1016/j.ijnurstu.2014.02.005 pmid: 24630378.
4. Fang C-K, Chen H-W, Liu S-I, Lin CJ, Tsai LY, Lai YL. Prevalence, detection and treatment of delirium in terminal cancer inpatients: a prospective survey. Jpn J Clin Oncol 2008;38:56-63. doi:10.1093/jjco/hym155 pmid:18238881.
5. LeGrand SB. Delirium in palliative medicine: a review. J Pain Symptom Manage 2012;44:583-94. doi:10.1016/j.jpainsymman.2011.10.013 pmid:22682074.
6. Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA 1996;275:852-7. doi:10.1001/jama.1996.03530350034031 pmid:8596223.
7. Bush SH, Leonard MM, Agar M, et al. End-of-life delirium: issues regarding recognition, optimal management, and the role of sedation in the dying phase. J Pain Symptom Manage 2014;48:215-30. doi:10.1016/j.jpainsymman.2014.05.009 pmid:24879997.
8. Morita T, Tei Y, Tsunoda J, Inoue S, Chihara S. Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manage 2001;22:997-1006. doi:10.1016/S0885-3924(01)00360-8 pmid:11738162.
9. Hosie A, Davidson PM, Agar M, Sanderson CR, Phillips J. Delirium prevalence, incidence, and implications for screening in specialist palliative care inpatient settings: a systematic review. Palliat Med 2013;27:486-98. doi:10.1177/0269216312457214 pmid:22988044.
10. National Institute for Health and Care Excellence. Delirium: prevention, diagnosis and management. NICE guideline 103. 2010. https://www.nice.org.uk/guidance/CG103? UNLID=71857637201581742332.
11. Kurita GP, Sjøgren P, Ekholm O, et al. Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study. J Clin Oncol 2011;29:1297-303. doi:10.1200/JCO.2010.32.6884 pmid:21357785.
12. Cobb JL, Glantz MJ, Nicholas PK, et al. Delirium in patients with cancer at the end of life. Cancer Pract 2000;8:172-7. doi:10.1046/j.1523-5394.2000.84006.x pmid:11898256.
13. Leonard M, Raju B, Conroy M, et al. Reversibility of delirium in terminally ill patients and predictors of mortality. Palliat Med 2008;22:848-54. doi:10.1177/0269216308094520 pmid: 18755829.
14. Bush SH, Kanji S, Pereira JL, et al. Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development. J Pain Symptom Manage 2014;48:231-48. doi:10.1016/j.jpainsymman. 2013.07.018 pmid:24480529.
15. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med 1990;113:941-8. doi:10.7326/0003-4819-113-12-941 pmid:2240918.
16. Gaudreau JD, Gagnon P, Harel F, Tremblay A, Roy MA. Fast, systematic, and continuous delirium assessment in hospitalized patients: the nursing delirium screening scale. J Pain Symptom Manage 2005;29:368-75. doi:10.1016/j.jpainsymman.2004.07.009 pmid: 15857740.
17. Sands MB, Dantoc BP, Hartshorn A, Ryan CJ, Lujic S. A single question in delirium (SQiD): testing its efficacy against psychiatrist interview, the confusion assessment method and the memorial delirium assessment scale. Palliat Med 2010;24:561-5. doi:10.1177/0269216310371556 pmid:20837733.
18. Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S. The memorial delirium assessment scale. J Pain Symptom Manage 1997;13:128-37. doi:10.1016/S0885-3924( 96)00316-8 pmid:9114631.
19. Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N. Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci 2001;13:229-42. doi:10.1176/jnp.13.2. 229 pmid:11449030.
20. Leonard MM, Nekolaichuk C, Meagher DJ, et al. Practical assessment of delirium in palliative care. J Pain Symptom Manage 2014;48:176-90. doi:10.1016/j.jpainsymman. 2013.10.024 pmid:24766745.
21. Siddiqi N, Harrison JK, Clegg A, et al. Interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev 2016;3:CD005563.pmid:26967259.
22. Candy B, Jackson KC, Jones L, Leurent B, Tookman A, King M. Drug therapy for delirium in terminally ill adult patients. Cochrane Database Syst Rev 2012;11:CD004770.pmid: 23152226.
23. de Stoutz ND, Bruera E, Suarez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 1995;10:378-84. doi:10.1016/0885-3924(95) 90924-C pmid:7673770.
24. Mercadante S, Bruera E. Opioid switching: a systematic and critical review. Cancer Treat Rev 2006;32:304-15. doi:10.1016/j.ctrv.2006.03.001 pmid:16624490.
25. Dev R, Dalal S, Bruera E. Is there a role for parenteral nutrition or hydration at the end of life?Curr Opin Support Palliat Care 2012;6:365-70. doi:10.1097/SPC. 0b013e328356ab4a pmid:22801468.
26. National Cancer Institute. Delirium (PDQ)-health professional version. 2015. http://www. cancer.gov/aboutcancer/treatment/side-effects/memory/delirium-hp-pdq.
27. Scotland NHS. Palliative care guidelines: delirium. 2014. http://www. palliativecareguidelines.scot.nhs.uk/guidelines/symptomcontrol/Delirium.aspx.
28. Canadian Coalition for Seniors' Mental Health. Guideline on the assessment and treatment of delirium in older adults at the end of life. 2010. http://www.ccsmh.ca/en/projects/delirium. cfm.
29. Seitz DP, Gill SS, van Zyl LT. Antipsychotics in the treatment of delirium: a systematic review. J Clin Psychiatry 2007;68:11-21. doi:10.4088/JCP.v68n0102 pmid:17284125.
30. Inouye SK, Marcantonio ER, Metzger ED. Doing damage in delirium: the hazards of antipsychotic treatment in elderly people. Lancet Psychiatry 2014;1:312-5. doi:10.1016/S2215-0366(14)70263-9 pmid:25285270.
31. Breitbart W, Marotta R, Platt MM, et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996;153:231-7. doi:10.1176/ajp.153.2.231 pmid:8561204.
32. Crawford GB, Agar M M, Quinn SJ, et al. Pharmacovigilance in hospice/palliative care: net effect of haloperidol for delirium. J Palliat Med 2013;16:1335-41. doi:10.1089/jpm. 2013.0230 pmid:24138282.
33. Agar M, Lawlor PG, Quinn SJ. Phase lll randomized double-blind controlled trial of oral risperidone, haloperidol, or placebo with rescue subcutaneous midazolam for delirium management in palliative care. 2015 Annual American Geriatrics Society Meeting in Washington DC, USA, May 15th-17th 2015. J Am Geriatr Soc 2015;63(suppl 1):S99.
34. Douglas IJ, Smeeth L. Exposure to antipsychotics and risk of stroke: self controlled case series study. BMJ 2008;337:a1227. doi:10.1136/bmj.a1227 pmid:18755769.
35. Maltoni M, Scarpi E, Rosati M, et al. Palliative sedation in end-of-life care and survival: a systematic review. J Clin Oncol 2012;30:1378-83. doi:10.1200/JCO.2011.37.3795 pmid: 22412129.
36. Cohen MZ, Pace EA, Kaur G, Bruera E. Delirium in advanced cancer leading to distress in patients and family caregivers. J Palliat Care 2009;25:164-71.pmid:19824277.
37. Breitbart W, Gibson C, Tremblay A. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 2002;43:183-94. doi:10.1176/appi.psy.43.3.183 pmid: 12075033.
38. Lawlor PG, Davis DH, Ansari M, et al. An analytical framework for delirium research in palliative care settings: integrated epidemiologic, clinician-researcher, and knowledge user perspectives. J Pain Symptom Manage 2014;48:159-75. doi:10.1016/j.jpainsymman. 2013.12.245 pmid:24726762.